Article info
PDFCorrespondence
No increased rate of SARS-CoV-2 infection for patients with inflammatory rheumatic diseases compared with the general population in the city of Hamburg (Germany)
- Correspondence to Dr Christof Iking-Konert, Nephrology and Rheumatology, Department of Medicine III, University of Hamburg Faculty of Medicine, Hamburg 20146, Germany; c.iking-konert{at}uke.de
Citation
No increased rate of SARS-CoV-2 infection for patients with inflammatory rheumatic diseases compared with the general population in the city of Hamburg (Germany)
Publication history
- Received June 24, 2020
- Accepted June 26, 2020
- First published August 7, 2020.
Online issue publication
November 10, 2022
Article Versions
- Previous version (7 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage